Aytu BioPharma (AYTU) to Release Quarterly Earnings on Thursday

Aytu BioPharma (NASDAQ:AYTU) is set to post its quarterly earnings results after the market closes on Thursday, September 26th.

Aytu BioPharma Stock Down 2.8 %

Shares of NASDAQ AYTU opened at $2.40 on Friday. The company has a market capitalization of $14.33 million, a PE ratio of -0.91 and a beta of -1.43. The stock’s 50 day moving average price is $2.56 and its 200-day moving average price is $2.85. Aytu BioPharma has a twelve month low of $1.53 and a twelve month high of $3.50.

Aytu BioPharma Company Profile

Aytu Biopharma, Inc, a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment. The Rx segment offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years and older, and Cotempla XR-ODT for patients from six to seventeen years old.